You are hereHome SectorsAlgeria
Misonix announces new distribution agreement for Algeria
Source: BI-ME , Author: Posted by BI-ME staff
Posted: Fri November 18, 2011 12:33 pm

INTERNATIONAL.  Misonix, Inc. (NASDAQ: MSON), a medical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for wound debridement, spinal surgery, cosmetic surgery, neurosurgery, laparoscopic surgery and other surgical applications, has entered into a new, two year, exclusive distribution agreement with SARL EXCELLENCE SANTE (SES) of Algiers, Algeria for the distribution of the SonaStar® Ultrasonic Surgical Aspirator and the BoneScalpelâ„¢ Ultrasonic Bone Cutter. 

The agreement provides SES with the rights to sell throughout Algeria.  Included in the agreement are annual minimum purchase requirements.  Initial product training is complete and open market sales are underway.
 
SES is a respected distributor of state-of-the-art medical devices and has successfully launched multiple new products into Algeria, including capital equipment-based surgical systems, and is well known for their commitment to service and physician training, particularly in the fields of Spine Surgery, Orthopedic Surgery and Neurosurgery.
 
The SonaStar is used by Neuro and General Surgeons for quick and efficient removal of both hard and soft tumors while sparing most vessels.  In addition, OsteoSculptâ„¢ bone sculpting technology can be employed with the SonaStar to safely remove osseous structures, thus providing access to the surgical site.
 
The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures.  It offers the convenience and speed of a power instrument without the danger associated with rotary sharps.
 
"Misonix is very pleased to have SES become our third distributor for emerging markets on the African continent.  Their reputation as a quality distributor of advanced medical equipment has been established," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix.  "Their commitment to clinical education and service matches Misonix's own values in these areas.  We are particularly pleased that they will be selling two of our key products throughout Algeria."
 
About Misonix:

Misonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices.  Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies.  Addressing a combined market estimated to be in excess of US$3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. 

Additional information is available on the Company's Web site at www.misonix.com.

 

MIDDLE EAST BUSINESS COMMENT & ANALYSIS

date:Posted: October 29, 2014
UAE. Total wealth in the GCC stood at US$ 1.7 tillion in 2014, up 4.75% from 2013; Total wealth in Saudi Arabia and UAE grew by 5%; Global household wealth up 8.3% to US$263 trillion, driven by the US and Europe, according to Credit Suisse Research Institute.
date:Posted: October 29, 2014
UAE. Significant increase in inflows of private capital into UAE in 2014; UAE seen as hub between Africa and Asia; Political stability remains a major factor driving flows; UAE clear winner in the region, as other GCC countries see net outflows of private capital.
date:Posted: October 28, 2014
INTERNATIONAL. Foreign policy is what a president wishes would happen; foreign affairs are what actually happen; the problem that Obama has, which has crippled his foreign policy, is that his principles have not been defined with enough rigor to provide definitive guidance in a crisis.
UAE. Total wealth in the GCC stood at US$ 1.7 tillion in 2014, up 4.75% from 2013; Total wealth in Saudi Arabia and UAE grew by 5%; Global household wealth up 8.3% to US$263 trillion, driven by the US and Europe, according to Credit Suisse Research Institute.
dhgate